Cervical cancer
Results
Phase 1
This study looked at whether pembrolizumab could improve treatment for cancer of the cervix.
Recruitment start: 22 December 2017
Recruitment end: 25 October 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Susan Lalondrelle
Biomedical Research Centre (BRC)
Merck, Sharpe & Dohme
Royal Marsden NHS Foundation Trust
Last reviewed: 18 Jul 2019
CRUK internal database number: 15406
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
